Gene Query: MRPL28

Dataset Description Geneva Score
The ribosomal prolyl-hydroxylase OGFOD1 decreases during cardiac differentiation, modulates translation and spliceosomal processes 27.9
Next Generation Sequencing Facilitates Quantitative Analysis of miR-29b-1 and miR-29a targets in tamoxifen-sensitive and tamoxifen-resistant human breast cancer cells 27.23
Distinct regulation of alternative polyadenylation and gene expression by nuclear poly(A) polymerases 26.23
The X-linked DDX3X RNA helicase dictates translation re-programming and metastasis in melanoma 21.77
ChIP-seq and RNA-seq in BGC823 cells after downregulation of GAS1 expression 21.49
A novel lncRNA GAS1 promotes gastric carcinogenesis and acts as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern [RNA-seq] 21.49
Lysine benzoylation is a novel histone mark [RNA-seq] 18.21
Lysine benzoylation is a novel histone mark 18.21
Modeling and characterization of the dynamic gene regulatory networks underlying cancer drug resistance based on time-course RNA-seq data 17.35
The long non-coding RNA MALAT1 contributes to the pathogenesis of multiple sclerosis through alternative splicing and backsplicing regulation 16.07
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 15.73
Biochemical fractionation of HEK293 nuclei and RNA-seq of chromatin-associated and soluble-nuclear RNA 15.54
Next Generation RNA Sequencing Analysis of AMPK Wild Type, AMPKα-KO and AMPKα1-2A U2OS cell Transcriptomes 14.73
Maintaining iron homeostasis is the key role of lysosomal acidity for cell proliferation 14.61
Crizotinib v. DMSO in SW480 cells 14.55
3’READS+, a sensitive and accurate method for 3’ end sequencing of polyadenylated RNA 14.45
NET-CAGE Characterizes the Dynamics and Topology of Human Transcribed Cis-regulatory Elements 14.3
mRNA expression profile of A549 cells and MSR-A549 cells with or without JQ1 treatment 14.26
A549 cells and MSR-A549 cells 14.26
Transcriptome analysis upon C6orf203 silencing 14.16
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 13.99
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 13.99
MPTAC determines APP fragmentation via sensing sulfur amino acid catabolism 13.26
SERPINA3- a novel keratinocyte differentiation promotor mediates epidermal barrier repair response in psoriatic lesion 13.12
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells [RNA-seq] 12.79
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells 12.79
Nucleosome dynamics in human colorectal cancer specimens reveal activation of a CNOT3-regulated pathway of embryonic stem cell self-renewal 12.7
Functional role of CPPED1 in trophoblasts. 12.18
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies [RNA-seq] 11.7
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies 11.7
Bach1 Regulates the Self-renewal and Mesendodermal Differentiation of Human Embryonic Stem Cells 11.63
IDH3a KO RNA-seq 11.5
Energy Metabolism during Anchorage-Independence 11.34
The effect of REST and its alternatively spliced transcript, REST-003, on breast cancer invasiveness 11.34
The Jumonji-domain histone demethylase inhibitor JIB-04 deregulates oncogenic programs and increases DNA damage in Ewing Sarcoma, resulting in impaired cell proliferation and survival, and reduced tumor growth 11.23
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_RNA-seq] 11.02
Gene expression changes in HSV-1 infected HeLa cells with knockdown of B2M 10.98
Probing the Global Cellular Responses to Lipotoxicity Caused by Saturated Fatty Acids 10.91
Global analysis of enhancer targets: Mosaic-seq 10.83
Uridilation by TUT4/7 restricts retrotransposition of human Line-1s 10.79
Widespread N6-methyladenosine-dependent RNA Structural Switches Regulate RNA-Protein Interactions 10.76
Combined Experimental and System-Level Analyses Reveal the Complex Regulatory Network of miR-124 during Human Neurogenesis [ZNF787] 10.76
DDX54 regulates transcriptome dynamics during DNA damage response [4SU-seq] 10.71
Nudt3 is a mRNA Decapping Enzyme That Modulates Cell Migration 10.61
DHX15 regulates CMTR1-dependent gene expression and cell proliferation 10.47
Proteinase-Activated Receptor 4 (PAR4) mediates cell membrane blebbing in a Gaq/11, Gai independent, RhoA and ß-arrestin-dependent manner. 10.42
Impact of flanking chromosomal sequences on localization and silencing by the ncRNA XIST 10.41
Whole Transcriptome RNASeq Data for Cell-Sorted Antibody Secreting Cells (ASC) 10.38
Interleukin-1β induces mitochondrial DAMP production to activate STING-dependent innate immune programs 10.22
Transcriptional effect of ETV1 knockdown in melanoma cells 10.08
Human Adipocytes Regulate Gene Expression in Triple-negative Breast Cancer Assessed by NGS Sequencing 10.05
U1 snRNP telescripting regulates size-function stratified human genome 9.97
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development [set 1] 9.93
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 1: RNA-seq) 9.88
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on PANC1 cells treated with CoCl2) 9.85
Transcriptome-wide study of the response of human trabecular meshwork cells to the substrate stiffness increase 9.82
A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters 9.77
High-throughput RNA sequencing on circular RNA profiles of human pancreatic cancer cell lines and gemcitabine resistant pancreatic cancer cell lines. 9.7
The stress granule transcriptome reveals principles of mRNA accumulation in stress granules. 9.66
NRDE2 negatively regulates nuclear exosome functions 9.63
Effect of 48h treatment with 100nM GSK2879552 on T-ALL cell lines LOUCY and PEER 9.47
The ZZ-type zinc finger of ZZZ3 modulates the ATAC complex-mediated histone acetylation and gene activation 9.42
Global analysis of ZNF217 chromatin occupancy in the breast cancer cell genome reveals an association with Eralpha 9.39
Gene expression analysis in U251 and U87 cells transduced with NANEP5 vector. 9.37
Adaptive resistance of melanoma cells to RAF inhibition via reversible induction of a slowly-dividing de-differentiated state 9.37
RNA-sequencing and MeDIP-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 9.34
RNA-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 9.34
Club cells surviving influenza A virus infection induce temporary non-specific anti-viral immunity 9.33
The effect of doxycycline-induced expression of host-cell-factor 2 (HCF-2) proteins on the global gene expression in HEK-293 cells 9.28
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells (RNA-Seq) 9.24
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells 9.24
Protein kinase A-mediated phosphorylation regulates STAT3 activation and oncogenic EZH2 activity 9.23
Activation of HOTTIP lncRNA perturbs HSC function leading to AML like disease 9.21
MDM2 and MDM4 are Therapeutic Vulnerabilities in Malignant Rhabdoid Tumors 9.19
Neurofibroma 9.17
Differential expression in wild-type and mutant neurofibroma and MPNST cell lines 9.17
Quiescent glioblastoma cells shift to an epithelial-mesenchymal transition-like gene program 9.17
Impact of dieldrin on transcription in Jurkat T cells 9.11
Next Generation Sequencing Facilitates Quantitative Analysis of SW480 cells and HPSE-knockdown SW480 cells Transcriptomes 9.0
Survival of pancreatic cancer cells lacking KRAS function 8.96
RNA-seq of young and quiescent MRC-5 human fibroblasts 8.88
transcriptomic profiling of HEK293 cells upon individual knockdown of the splicing factors RBM17, U2SURP or CHERP 8.64
Long non-coding RNA TYKRIL controls pericyte function and survival in the cardiovascular and central nervous system through regulation of p53 activity and PDGFRß expression 8.63
Identification of mRNAs with reduced ribosomal loading upon knock-down of translation factor DAP5 from hESCs. 8.62
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_1A_PI3K_RNA-seq] 8.6
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex 8.6
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response 8.51
Integrative classification of human coding and non-coding genes based on RNA metabolism profiles 8.51
Expression data for KDM1B knockdown in Glioma-Initiating Cells (GICs) 8.45
KLF6-dependent transcription in renal cancer cells 8.39
Global Bidirectional Transcription of the Epstein-Barr Virus Genome During Reactivation 8.33
The comparison of high-throughput single-cell RNA-seq methods 8.3
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection 8.25
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection (RNA-sequencing) 8.25
Fisetin induces autophagy in pancreatic cancer cells via endoplasmic reticulum stress- and mitochondrial stress-dependent pathways 8.23
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype [RNA-Seq] 8.22
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype 8.22
Patient-derived luminal breast cancer xenografts with progestins 8.21
RNAseq analysis of patient-derived luminal breast cancer xenografts treated with progestins 8.21
Human embryonic stem cell, chimpanzee induced pluripotent stem cell, orangutan induced pluripotent stem cell, rhesus embryonic stem cell, and their derived cortical organoid RNA-seq 8.17
Transcriptome-wide identification of splicing defects upon XAB2 knockdown 8.17
The SPOP-containing Complex Functions as an E3 Ligase for SETD2 to Regulate Gene-Specific H3K36me3-Coupled Alternative Splicing 8.14
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells 8.06
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells [RNA-seq] 8.06
Transcriptomic analysis of T84 colon carcinoma cell line treated with trametinib, JQ1 or their combination 7.99
Regulation of cellular heterogeneity and rates of symmetric and asymmetric divisions in triple-negative breast cancer 7.96
CXCR4 is a host factor that regulates Plasmodium development in hepatocytes 7.96
Human Treg IL-12 stimulation 7.96
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs (expression) 7.86
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs 7.86
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (human 3' mRNA-seq) 7.83
Thymine DNA Glycosylase as a novel target for melanoma: effect of TDG silencing on gene expression in SK-mel-28 melanoma cells 7.82
Transcriptional profiling of MCF7 cells treated with H3B05942, E2, or standard of care compounds 7.79
Nuclear import of the DSCAM-cytoplasmic domain drives signaling capable of inhibiting synapse formation 7.73
hTERT promotes cell adhesion and migration independent of telomerase activity 7.68
Transcriptome sequencing of human coronary artery smooth muscle cell under treatment of nitrated fatty acid 7.66
MicroRNA (miR)-211 loss promotes metabolic vulnerability and BRAF inhibitor sensitivity in melanoma 7.6
Dynamic epigenetic remodeling underlies microRNA-mediated transdifferentiation of human adult fibroblasts into neuronal subtypes 7.57
Mitochondrial dsRNA triggers antiviral signalling in humans 7.55
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer (RNA-seq) 7.54
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer 7.54
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors [RNA-seq] 7.51
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors 7.51
RNA-seq transcriptonal profiling in human primary adult erythroid progenitor cells (ProEs) after shRNA-mediated depletion of TFAM and PHB2 expression 7.47
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 7.46
Impact of GDF15 expression of ovarian cancer cell on stroma and Cisplatin responses 7.41
Ectoderm specification of H1 human embryonic stem cells 7.36
Understanding the reproducibility and robustness of the kidney organoid differentiation protocol using RNA-seq 7.32
Prolyl hydroxylation regulates protein degradation, synthesis, and splicing in human induced pluripotent stem cell-derived cardiomyocytes 7.28
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 7.27
High-throughput sequencing of pluripotent cells 7.19
Expression analysis of genes modulated after knock-down of lncRNA CHROME. 7.17
MOF acetyl transferase regulates transcription and respiration in mitochondria 7.14
Tumors with TSC mutations are sensitive to CDK7 inhibition through NRF2 and glutathione depletion 7.14
Integrative Analysis of Tamoxifen-resistant Cell Line Models Based on Sequencing Genomes, Transcriptomes and Epigenomes 7.1
Integrative Analysis of Tamoxifen-resistant Cell Line Models Based on Sequencing Genomes, Transcriptomes and Epigenomes [seq] 7.1
Analysis of gene expression, motif and pattern of m6A modified region and m6A enrichment level in Ocular melanoma and Melanocyte cell lines. Gene expressin analysis of METTL3 knock down in PIG1, ALKBH5 knock down and HINT2 over expression in OCM1. 7.07
Expression level comparison under dividing and quiescent states in human primary fibroblasts 7.06
Gene expression changes after LOC550643 silencing 7.05
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-seq C-terminal mutant] 7.03
Discovery of cis-spliced chimeric RNAs between adjacent genes in human prostate cells 6.89
TALENs-mediated gene disruption of FLT3 in leukemia cells: Using genome-editing approach for exploring the molecular basis of gene abnormality 6.87
Role of XRN2 ribonucleolytic activity in RNA metabolism 6.86
Next-generation sequencing of human dermal fibroblasts transdifferentiated towards the otic lineage 6.82
Proteomics identifies a marker signature of MAPKi resistance in melanoma 6.77
CROP-Seq in Primary Human T Cells 6.75
High-Throughput Kinetic Analysis of Fractional Killing 6.72
RNA-seq of HDAC2-disrupted 293FT cells by CRISPR-Cas9 6.72
Biosynthesis of histone messenger RNA employs a specific 3' end endonuclease 6.66
A novel CRISPR-engineered prostate cancer cell line defines the AR-V transcriptome and identifies PARP inhibitor sensitivities. 6.65
Coordination of neuron production in mouse and human cerebral cortex by the homolog of Drosophila Mastermind protein 6.64
Image based identification and targeting of cancer stem cells in pancreatic adenocarcinoma (PDAC) 6.62
Gene expression profile of LMSU gastric cancer cell p53 KO and KD 6.62
Chemical Modulation of Glycolysis Regulates the KEAP1-NRF2 Pathway Through a Metabolite-Induced Posttranslational Modification 6.61
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition [RNA-Seq] 6.59
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition 6.59
Effect of SHP2 inhibition on hepatic stellate cell transcriptome. 6.59
Tracking distinct RNA populations using efficient and reversible covalent chemistry 6.58
Identification of diverse target RNAs that are functionally regulated by human Pumilio proteins 6.51
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and AXL-/- astrocytes Transcriptomes 6.51
The effect of engineered del(7q) on induced pluripotent stem cells (iPSCs) derived from patients with Shwachman Diamond Syndrome (SDS). 6.47
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 6.47
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 (RNA-Seq) 6.47
Gene expression profiles in response to proanthocyanidins in pancreatic cancer cells 6.41
Microprocessor mediates transcription termination in long noncoding microRNA genes 6.38
Biased Expression of the FOXP3Δ3 Isoform in Aggressive Bladder Cancer Mediates Differentiation and Cisplatin Chemotherapy Resistance 6.29
Transcriptome profiling of HepG2 cells upon treatment of the menin-MLL inhibitor MI-503 or DMSO 6.29
Heterozygous p53-R280T mutation promotes proliferation of NPC cells through activating PI3K/Akt signaling pathway 6.27
LncRNA NONHSAT113026 represses renal cell carcinoma tumorigenesis through interacting with NF-κB/p50 and SLUG 6.26
Transcriptomic profiling of human HAP1 cells before and after nutrient deprivation 6.24
Human HAP1 cells before and after nutrient deprivation 6.24
Spatially Constrained Tandem Bromodomain Inhibition Bolsters Sustained Repression of BRD4 Transcriptional Activity for TNBC Cell Growth 6.22
RNA seq comparison between scrambled and shGRP78 cells 6.21
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) 6.2
HMGA2 Promotes Long-Term Engraftment and Myelo-Erythroid Differentiation of Human Hematopoietic Stem and Progenitor Cells 6.17
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [ESRP KD] 6.17
Illumina Total RNA-seq in HeLa 6.13
Stem and effector CD8 T-cells from human cancers 6.13
PRDM1 inhibits proliferation of human colon cancer organoids 6.12
Understanding the Mechanistic Contribution of Herbal Extracts in Compound Kushen Injection with Transcriptome Analysis 6.12
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 6.07
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc [RNA-Seq] 6.07
scRNASeq analysis of cycling cardiomyocytes 6.07
CENPA-Bound Genes and Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cells 6.07
Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cell Lines 6.07
BRG1 governs Glucocorticoid Receptor interactions with chromatin and pioneer factors across the genome 6.06
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells [RNA-Seq] 6.02
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells 6.02
Dynamics of the human and viral m6A RNA methylomes during HIV-1 infection of T cells 5.97
Epigenetic Inactivation of Cysteine Dioxygenase Type 1 Contributes to ROS-dependent Progression of Colorectal Cancer 5.93
Human Induced Pluripotent Stem Cells Recapitulate Breast Cancer Patients’ Predilection to Doxorubicin-Induced Cardiotoxicity 5.93
Gene expression profile of HGC27 and LMSU gastric cancer cell p53 KO and KD 5.91
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation 5.91
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation (Human_RWPE1_RNA-Seq) 5.91
RNAseq of cell lines with knocked in ESR1 mutations 5.9
RNA sequencing of CACO-2 cells incubated with bifidobacteria grown on human milk oligosaccharides. 5.87
Canonical poly(A) polymerase activity promotes the decay of a wide variety of mammalian nuclear RNAs 5.84
RNA-sequencing WT vs SOCS3 knockout Glioblastoma stem-cells 5.81
Transcriptomic analysis of senescent cells upon PTBP1 knockdown. 5.8
Oncogenic MYC induces a dependency on the spliceosome in human cancer 5.79
The LIN28B/let-7 axis is a novel therapeutic pathway in Multiple Myeloma 5.79
RRAD, IL4I1, CDKN1A, and SERPINE1 genes are potentially co-regulated by NF-κB and p53 transcription factors in cells exposed to high doses of ionizing radiation [RNA-Seq] 5.79
Expression and functions of long noncoding RNAs during human T helper cell differentiation 5.76
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-seq of KLF6 KO) 5.74
In Vitro and In Vivo Modulation of Alternative Splicing by the Biguanide Metformin. 5.74
Transcriptomic analysis of senescent cells upon PTBP1 knockdown and EXOC7 knockdown 5.71
RNA-seq and ChIP-seq analysis of BMI1 or RING1B-silenced prostate cancer cells C4-2 5.71
Differential expression of pancreatic cancer PANC1 cells treated with pilocarpine 5.67
K562 polyA RNA-Seq 5.65
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (ChIP-seq & RNA-seq datasets) 5.65
The m 6 A-methylase complex recruits TREX and regulates mRNA export. 5.61
Heterogeneous nuclear ribonucleoprotein C1/C2 links transcriptional and splicing actions of 1,25-dihydroxyvitamin D 5.58
Replicative senescence is associated with nuclear reorganization and DNA methylation at specific transcription factor binding sites (RNA-seq) 5.58
Replicative senescence is associated with nuclear reorganization and DNA methylation at specific transcription factor binding sites 5.58
In vivo generation of post-infarct human cardiac muscle by laminin-promoted cardiovascular progenitors [LN-521 or LN-521+LN-221] 5.55
Global gene expression profile of dasatinib-resistant RCH-ACV cells 5.52
RNA-seq of human aneuploid cell lines with Trisomy 21 5.52
Identification of differential expressed genes of JQ1 or JQ1+Bortezomib in colorectal cancer cells 5.51
Genome wide transcriptome analysis of palbociclib or GSK3326595 treated A375 cells [Palbociclib_GSK_RNASeq] 5.51
BBBomics - Human Blood Brain Barrier Transcriptomics Hub [RNA-seq] 5.49
BBBomics - Human Blood Brain Barrier Transcriptomics Hub 5.49
Patient iPSC-Derived Neurons for Disease Modeling of Frontotemporal Dementia with Mutation in CHMP2B 5.45
Regulation of poly(A) tail and translation during the somatic cell cycle 5.45
UMI-count modeling and differential expression analysis for single-cell RNA sequencing 5.39
Regulatory network controlling tumor-promoting inflammation in human cancers [RNA-seq] 5.38
Regulatory network controlling tumor-promoting inflammation in human cancers 5.38
LncRNA NMR knockdown and overexpression in esophageal squamous cell carcinoma cell lines 5.36
Allogeneic mature human dendritic cells generate superior alloreactive regulatory T cells in the presence of IL-15 5.34
p38 SAPK and SKIIP induced changes in alternative splicing patterns upon osmostress 5.34
Total RNA deep sequencing (ribosomal depleted) of human umbilical vein endothelial cells exposed to hypoxia (0.2%) for 12h and 24h or kept under normoxic conditions. 5.32
Endothelial gene expression analysis 5.32
Identifying markers predicting successful graft outcome for clinical translation of hESC-based cell therapy for Parkinson’s disease 5.3
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development 5.28
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner 5.26
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner [Huh-7] 5.26
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells [RNA-seq] 5.18
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells 5.18
RNA-seq, ChIP-seq and single cell RNA-seq of human skin Langerhans cells 5.15
A common cell state in Triple Negative Breast Cancers represents a druggable vulnerability 5.14
Deletion of DXZ4 on the human inactive X chromosome eliminates superdomains and impairs gene silencing 5.11
TWIST1-induced microRNA-424 drives an intermediate epithelial-to-mesenchymal transition that opposes metastasis 5.1
Novel mutations segregating with Complete Androgen Insensitivity Syndrome and their molecular characteristics. 5.07
Ets homologous factor has critical roles in epithelial dysfunction in airway disease [RNA-seq] 5.01
Ets homologous factor has critical roles in epithelial dysfunction in airway disease 5.01
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 4.99
METTL3 and WTAP 4.96
Cooperation of GRSF1 and the mitochondrial degradosome (hSuv3-PNPase complex) in degradation of mitochondrial RNA 4.9
Diffuse Large B Cell Lymphoma cell line with Acquired Resistance to PI3Kδ Inhibitor Idelalisib 4.87
ChIP-seq and RNA-Seq analyses of epithelial and mesenchymal cells - HMLE, N8, N8-CTx 4.84
RNA-Seq comparisons of gene expression profiles of epithelial and mesenchymal cells - HMLE, N8, N8-CTx 4.84
RNA-Sequencing data of Varicella Zoster Virus (VZV)-infected human dermal fibroblasts (HDF) 4.82
Mutant KRAS/BRAF Reprograms the Enhancer Landscape via GATA1 to Drive Chemoresistance 4.76
DNMT and HDAC inhibitors globally induce cryptic TSSs encoded in long terminal repeats 4.71
SRSF1 role in cellular gene expression and splicing 4.7
Nascent RNA Sequencing after NMYC activation in SH-EP MYCNER cells 4.64
Total RNA sequencing of WT intestinal orgaonids. 4.58
RNA-seq analysis of human cardiosphere cells with different tubule supportive potential 4.56
Gene induction by the USP6 oncogene in response to interferon 4.55
Transcriptome wide analysis of translation efficiency in MCF7 cells using polysome profiling with and without eIF4A inhibition by hippuristanol treatment 4.46
Bioinformatics analysis of transcriptome related to blood stasis syndrome in diabetes mellitus patients 4.43
Stretch-Enhancers Delineate Disease-Associated Regulatory Nodes in T Cells 4.38
RNA-Sequencing approach for the identification of novel long non-coding RNA biomarkers in colorectal cancer 4.35
A combinatorial screen of the CLOUD uncovers a synergy targeting the androgen receptor 4.34
Innate-like activation of mucosal-associated invariant T cells in mycobacterial infection 4.33
A systematic analysis of nuclear heat-shock protein 90 identifies a metazoan-specific regulatory module 4.31
Expanding the Nucleoside Recoding Toolkit: Revealing RNA Population Dynamics with 6-thioguanisine 4.29
Cis-SAGe fusion RNAs in transcription splicing factors knocking-down 293T cells 4.28
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma 4.25
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma (RNA-Seq) 4.25
HOXC6 affects the malignant phenotype of esophageal squamous cell carcinoma cells 4.23
Transcriptome wide identification of retained introns upon depletion of the splicing factors SNW1 or PRPF8 4.22
Human gut derived-organoids as model to study gluten response and effects of microbiota bioproducts in celiac disease 4.2
RNAseq of CD8+ and CD8- MAIT cells in human peripheral blood 4.16
LncPRESS1 is a p53-regulated lncRNA that safeguards pluripotency by disrupting SIRT6 mediated de-acetylation of histone H3K56 4.14
Antiviral innate immunity of hepatitis C virus-infected stem cell-derived hepatocytes 4.12
A Novel Population of Human Cardiac Resident Mesenchymal Stem Cells 4.1
Comparative whole-transcriptomic analysis between normal and AKAP-Lbc-depleted human embryonic stem cells 4.1
Transcriptomic changes mediated by β-amyloid in human aortic endothelial cells (HAOEC) 4.1
Effect of PRDM11 depletion in U2932 cells 4.1
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (RNA-seq dataset) 4.09
Gene expression profiling of leukemia cells following asparagine depletion 4.07
Binding to SMN2 pre-mRNA-Protein complex elicits specificity for small molecule splicing modifiers 4.06
RNA sequence of mRNA in HUVEC cells after depleting EGFL6 4.0
TT-Seq captures the human transient transcriptome 3.91
Transcriptome sequencing of K-562 cells 3.88
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq rescue_SS] 3.88
RNA-seq on Enasidenib or DMSO Treated CD71+ Cells from Umbilical Cord Blood (UCB) 3.85
Cajal bodies are linked to genome conformation [RNA-Seq] 3.83
Cajal bodies are linked to genome conformation 3.83
Hematopoietic Stem and Progenitor Cells from Human Pluripotent Stem Cells via Transcription Factor Conversion of Hemogenic Endothelium 3.83
SNHG15 is a bifunctional MYC-regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF 3.79
Triple vectors expand AAV transfer capacity in the retina 3.78
Effect of FGF13 depletion on the H460 cell line 3.76
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 2] 3.73
Studying the selectivity of a small molecule Synucleozid on transcriptome 3.63
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 [RNA-seq] 3.61
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 3.61
RNA-SEQ assay for wild type and CRISPR induced endoglin knockout human pulmonary artery smooth muscle cells (PASMC) 3.61
Suppression of NAF-1 in Breast Cancer Cells Reduces their Tumorigenicity by Interfering with Cellular Iron Distribution and Metabolism and Ensuing ROS Formation and Apoptosis 3.61
Knockout human reveal an essential role for Paternally Expressed 10 (PEG10) in JEG3 cell line development 3.6
Ribosome profiling upon inhibition of eIF4A 3.57
Transcriptomic analysis of differential expressed genes of human tonsillar epithelial cells UT-SCC-60B in response to EV71 infection 3.57
Canonical and non-canonical regulatory roles of androgen receptor variant 7 in prostate cancer 3.55
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression 3.53
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression [RNA-seq] 3.53
Expression profiling of MCF-7 cells with treatment of TCDD 3.5
Expression profiling of MCF-7 cells with 10nM treatment of TCDD 3.5
TimeLapse-seq: adding a temporal dimension to RNA sequencing through nucleoside recoding 3.45
Tracking transcriptional changes in a species-specific manner during experimental hepatoblastoma progression in vivo 3.43
Differential Protein Occupancy Profiling of the mRNA Transcriptome 3.37
Single-cell analysis of human kidney organoids 3.37
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 3.36
RNA deep sequencing analysis of glioma stem cells(GSCs) and non-GSCs 3.34
RNA editing in nascent RNA affects pre-mRNA splicing 3.3
Novel Non-catalytic Substrate-selective p38α-specific MAPK Inhibitors with Endothelial-Stabilizing and Anti-inflammatory Activity 3.28
SREBP1 drives Keratin 80-dependent cytoskeletal changes and invasive behavior in endocrine resistant ERα breast cancer 3.27
Iron response of HepG2 cells 3.21
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation [bulk] 3.15
Single-cell RNA Sequencing Resolves Spatiotemporal Development of Pre-thymic Lymphoid Progenitors and Thymus Organogenesis in Human Embryos 3.14
Single-Cell RNA Sequencing Reveals Metallothionein Heterogeneity during hESC Differentiation to Definitive Endoderm [RNA-Seq] 3.11
EGR1-controlled transcriptome of T HESCs 3.05
Global host gene expression changes in KSHV+ PEL cells upon KSHV reactivation 3.04
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [RNA-Seq III] 3.02
Class I histone deacetylases HDAC1, 2 and 3 are histone decrotonylases 3.02
Knock-down of Ror1 in MDA-MB-231 cell line decreases cell invasiveness 2.99
Mutations in EBF3 disturb transcriptional profiles and cause intellectual disability, ataxia and facial dysmorphism 2.99
Transciptome profiling of NoDice and RNaseIII null cells prior to and after polyIC treatment 2.99
RNA seq with AML (NB4) cells upon FTO inhibition 2.96
The Developmental Heterogeneity of Human Natural Killer Cells Defined by Single-cell Transcriptome 2.96
CLIC5: a novel ETV6 target gene in childhood acute lymphoblastic leukemia 2.92
Decoding breast cancer tissue-stroma interactions using species-specific sequencing 2.88
Measuring the effect of MYC on transcription during the DNA double-strand break response by RNA-seq of newly synthesized transcripts 2.86
transcriptome studies of BRD4 inhibitor BDF-1253 on renal clear carcinoma 786-O cells 2.86
ARID1A is a critical regulator of luminal identity and therapeutic response in oestrogen receptor-positive breast cancer (RNA-Seq) 2.86
The antineoplastic drug, trastuzumab, dysregulates metabolism in iPSC derived cardiomyocytes. 2.84
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex (RNA-Seq I) 2.84
Coordinate regulation of alternative pre-mRNA splicing events by the human RNA chaperone proteins hnRNPA1 and DDX5 2.82
Positively selected enhancer elements endow tumor cells with metastatic competence 2.77
Transcriptome analysis of human cumulus cells reveals hypoxia as the main determinant of follicular senescence. 2.73
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition [RNA-Seq] 2.72
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition. 2.72
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq 2] 2.68
Identification of the RB loss-induced transcriptome in prostate cancer [RNA] 2.66
Identification of the RB loss-induced transcriptome and E2F1 cistrome in prostate cancer 2.66
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 2.66
Isogenic patient-derived human iPSCs, wild-type or heterozygous for PIK3CA-E418K 2.59
Effect of BB608 on Gene Expression in HNSCC Cell Line 2.57
The transcriptome effect of overexpressing EZH2 in MCF7 2.5
Transciptomic profiling of human fetal lung samples 2.49
T47D xenografts treated with various combinations of ER- and PR-targeting therapies 2.46
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 2.43
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid 2.42
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid [TEMRA] 2.42
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation [RNA-Seq] 2.39
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation 2.39
Inheritable Silencing of Endogenous Genes by Hit-and-Run Targeted Epigenetic Editing 2.33
Poly(A)-ClickSeq resolves CF25-mediated alternative poly-adenylation, HeLa 2.31
Human Embryoid Body Transcriptomes Reveal Maturation Differences Influenced by Size and Formation in Custom Microarrays 2.26
Human Treg NaCl stimulation 2.22
Synergy from Gene Expression and Network Mining (SynGeNet) method predicts genotype-specific synergistic drug combinations in melanoma 2.2
RNA-seq analysis upon ARID1B overexpression 2.17
Pre-mRNA Splicing is Facilitated by an Optimal RNA Polymerase II Elongation Rate 2.17
Role for the Transcriptional Activator ZRF1 in Breast Cancer Progression and Endocrine Resistance 2.15
Transcriptional changes in lymphoma cells induced by LSD1 depletion 2.14
Histone demethylase LSD1 is required for germinal center formation and BCL6 driven lymphomagenesis 2.14
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery (RNA-seq data set) 2.14
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery 2.14
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 2.13
RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 2.12
RNA-seq and small RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 2.12
RNA-seq after siRNA targeting DDX24 applied to iHUVECs cell lines 2.12
YAP and MRTF-A, transcriptional co-activators of RhoA- mediated gene expression, are critical for glioblastoma tumorigenicity 2.11
Comparative total RNA and mRNA sequencing and systems analysis reveals nascent transcriptional response to early HIV-1 infection in a CD4+ T cell line 2.11
Analysis of an artificial zinc finger epigenetic modulator: widespread binding but limited regulation 2.05
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection 2.05
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection [RNA-seq] 2.05
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B-cell Responses to Influenza Hemagglutinin 2.05
Single amino acid change underlies distinct roles of H2A.Z subtypes in human syndrome 1.99
A robust qualitative transcriptional signature for the early diagnosis of gastric cancer 1.99
The bromodomain protein BRD4 regulates splicing during heat shock 1.94
Transcriptional profiling of SF295 cells following MTF1 knockout by CRISPR/Cas9 1.93
A transcriptome dataset revealing the molecular features of breast cancer stem cells 1.83
miRNAs affected by antagomiR-17 treatment 1.77
Functional significance of the HIV-1 Tat signature amino acid residues 1.76
Molecular characterization of BRSK2 and BRSK1 kinases as negative regulators of the NRF2 transcription factor 1.76
Integrated epigenomic and transcriptomic profiling of terminal human erythropoiesis [TMCC2] 1.75
Transcriptome sequencing after MAGOHB knockdown in MAGOH-deleted or non-deleted cancer cells 1.73
CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary (I) 1.68
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 1.65
Gene expression and chromatin organization changes in lamin A/C haploinsufficient human induced pluripotent stem cell-derived cardiomyocytes 1.64
Gene expression and chromatin organization changes in lamin A/C haploinsufficient human induced pluripotent stem cell-derived cardiomyocytes [RNA-seq] 1.64
A Non-Canonical Nuclear Activity Triggered by Small RNAs and Argonaute Proteins in Human Cells 1.64
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 [stranded] 1.63
TrapSeq: An RNA Sequencing-based pipeline for the identification of genetrap insertions in mammalian cells 1.62
Hsa-miR-139-5p/HNRNPF axis modulates gene-transcripts balance in thyroid cancer cells 1.62
The mRNA export receptor NXF1 coordinates transcriptional dynamics, alternative polyadenylation and mRNA export 1.57
Epigenome Editing by CRISPR/Cas9 Repressors for Silencing of Distal Regulatory Elements 1.4
Characterisation of HIF-dependent alternative isoforms in pancreatic cancer 1.38
Subcellular pathways shared by afflicted patients and mutant mice identify a new drug treatment for aortic aneurysm in Marfan syndrome 1.38
Prolyl Hydroxylase Substrate Adenylosuccinate Lyase Is An Oncogenic Driver In Triple Negative Breast Cancer 1.36
Genome-wide discovery of human splicing branchpoints 1.31
RNA-Seq data of NCI-H82 cells expressing a Dox-On pRB (pTripZ RB1) grown in the presence or absence of DOX and then treated with vehicle or AZD2811. 1.3
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders 1.29
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders [lnc-Nr2f1 overexpression] 1.29
Transcriptome Profiling Reveals the key genes and pathways involved in polycystic ovary syndrome [RNA-seq] 1.28
Identification of epigenetic interactions between miRNA and DNA methylation associated with polycystic ovarian syndrome 1.28
Copper Regulation of HIF-1 Transcription Activity 1.26
Copper Regulation of HIF-1 Transcription Activity [RNA-seq] 1.26
TFPa/HADHA is required for fatty acid beta-oxidation and cardiolipin re-modeling in human cardiomyocytes 1.25
Effect of ILF3 depletion in HeLa cells on RNA steady state levels 1.25
Poly(ADP-ribose) polymerase 1 is necessary for coactivating hypoxia-inducible factor-1-dependent gene expression by Epstein-Barr virus latent membrane protein 1 1.22
Whole transcriptome sequencing of the human thyroid primary cells with knock-down of the NRG1 gene 1.18
Intrinsic Plasma Cell Differentiation Defects in BENTA Patient B cells 1.15
RNA-seq differential expression studies: more sequence, or more replication? 1.12
Transcriptome Analysis Reveals Distinct Responses to Physiologic versus Toxic Manganese Exposure in Human Neuroblastoma Cells 1.1
Tissue-resident memory T cells mediate immune homeostasis in the human pancreas through the PD-1/PD-L1 pathway 1.06
A20 regulates canonical wnt-signaling through an interaction with RIPK4 1.02
The Hippo pathway kinase LATS1 scaffolds Beclin1 in autophagy regulation in hepatocellular carcinoma 0.99
Comparative Transcriptomic Analysis of Hematopoietic System Across Species by Microwell-Seq 0.96
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (TLR perturbation Bulk RNA-Seq) 0.95
Genome-wide analysis of the Integrator complex (HTS) 0.94
Genome-wide analysis of the Integrator complex 0.94
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 0.93
Microvesicle-mediated delivery of miR-1343: impact on markers of fibrosis 0.91
Interaction between mitoNEET and NAF-1 in cancer cells 0.88
Macrophages redirect phagocytosis by non-professional phagocytes and influence inflammation 0.87
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 0.86
Profiling gene expression changes in ovarian cancer cells seeded on 3D organotypic culture of omentum 0.86
RNA-seq data for non-targeting siRNA and CDK11 siRNA transfection in SHhES8 cells 0.84
Human Cord Blood Sorted Live Cell Erythroblasts RNA-Seq 0.8
Combinatorial Regulation Mediated by Biochemically Distinct Forms of SWI/SNF [RNA-Seq] 0.79
Genome-Wide Transcriptional Regulation Mediated By Biochemically Distinct Forms of SWI/SNF 0.79
Loss of Function Mutations in ETS2 Repressor Factor (ERF) Reveal a Balance Between Positive and Negative ETS Factors Controlling Prostate Oncogenesis [22PC RNA-seq] 0.79
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 0.78
Evolution of an lncRNA leads to a primate specific modulation of alternative splicing 0.78
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 0.75
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 0.75
Identification and mitigation of pervasive off-target activity in CRISPR-Cas9 screens for essential non-coding elements 0.74
Interactome (iCLIP) and Translatome ( Polysome profiling) of Musashi 2 (MSI2) targets in K562 0.73
Generation and persistence of human tissue-resident memory T cells in lung transplantation 0.73
RNA-Seq of polysome profiling fractions and whole cell lysates of UVB-irradiated N-TERT keratinocytes 0.73
Expression charcaterization of an internal protocol developed to differentiate RPE cells 0.71
RNA-Seq of PRMT1 overexpression ECA109 cells 0.69
RNA-seq of human foreskin fibroblast cells lacking RB, p130, and p107 treated with doxorubicin. 0.67
Concomitant BCORL1 and BRAF mutations in vemurafenib-resistant melanoma cells 0.67
Functional TRIM24 degraders via conjugation of ineffectual bromodomain and VHL ligands [RNA-seq] 0.64
Comparative Analysis of Cas9 Activators Across Multiple Species 0.62
Activin/Smad2-induced H3K27me3 reduction is crucial to initiate mesendoderm differentiation of ES Cells 0.61
In search for materials able to be colonized by a normal endothelium: сharacterization and NGS gene expression profiling of human primary endotheliocytes cultivated on electrospun 3D matrices 0.57
RNA sequencing (RNA-SEQ) of Human endothelial cells (HUVEC) in LFS, sFRP2OE, and WT conditioned media 0.57
NSD2 overexpression links drives clustered chromatin and transcriptional changes in a subset of insulated domains of insulated domains 0.57
The RNA binding protein IGF2BP3 promotes hematopoietic progenitor cell proliferation by targeting leukemogenic pathways 0.53
Transcriptome-wide profiling of poly(A)-tail length, translation efficiency and mRNA stability using TED-seq, mRNA-seq, Ribo-seq and PRO-seq in ER stress conditions 0.49
Enhancer activation during EGF response 0.47
Genome-wide DNA hypomethylation and RNA:DNA hybrid accumulation in Aicardi-Goutières syndrome 0.47
Cystathionine-β-Synthase Promotes Colon Carcinogenesis 0.47
Functional genomic analysis of the haploinsufficient tumor suppressor, CUX1 0.43
Maternal-biased H3K27me3 correlates with paternal-specific gene expression in the human morula 0.42
DHX36 is the missing link to understand RNA G-quadruplex structures, mRNA stability, and translation [RNA-seq] 0.41
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer 0.41
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer (RNA-seq) 0.41
Widespread Transcription beyond mRNA 3’ Ends Yields Abundant Regulatory RNAs 0.41
miR941 overexpression experiment 0.38
Histone H3.1K27 methylation promotes NHEJ by antagonizing FANCD2 on Chromatin 0.36
Transcription factors and stress response gene alterations in human keratinocytes following Solar Simulated Ultra Violet Radiation 0.36
PolyA-sequencing in Kelly and Kelly E9R neuroblastoma cells treated with THZ531 or DMSO 0.35
Transcriptome analysis of V336Y mutant mitochondrial ribosomal protein in human HEK293 cell line 0.35
MYC interacts with the G9a histone methyltransferase to drive transcriptional repression and tumorigenesis 0.35
CRISPR-Cas9 based screen for p53-bound enhancers that function in oncogene-induced senescence 0.32
Drug combination of 17-AAG and Belinostat on MDA-MB-231 breast cancer cells 0.31
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network with PRC2 [RNA-seq] 0.3
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network 0.3
Transcriptome-wide off-target RNA editing induced by CRISPR-guided DNA base editors [Modifications - screen] 0.28
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 0.26
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 0.26
Transcriptomic Analysis Of circRNAs/miRNAs/mRNAs upon Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection 0.25
Hsa-miR-371a-5p and hsa-miR-518a-3p regulated genes in choriocarcinoma cells 0.24
12hr 5-FU treatment vs. DMSO in SJSA cells (from 'A kinase independent role for CDK19 in p53 response') 0.23
Transcriptome analysis of human embryonic stem cells (hESCs) upon siRNA-mediated knockdown of hESC-essential genes 0.2
RNA-seq data from human lymphoma cell lines 0.2
ChIP-seq and RNA-seq from human lymphoma cell lines 0.2
Transcriptome of diurnal human blood neutrophils 0.19
m6A/m-Seq of human B-lymphocyte cell lines from healthy controls and major depressive disorder patients 0.19
The role of m6A/m-RNA methylation in stress response regulation 0.19
Perlman syndrome nuclease DIS3L2 controls cytoplasmic non-coding RNAs and provides surveillance pathway for maturing snRNAs 0.19
Transcriptomic analysis to underly the heterogeneity between 4 cellular models derived from patients diagnosed with pediatric high-grade gliomas under controlled atmosphere (modulation of oxygen level). 0.16
Identification of miRNA-mRNA regulatory network for Human Atrial Aging 0.16
Identification of miRNA-mRNA regulatory network for Human Atrial Aging [mRNA] 0.16
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing 0.15
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing (RNA-seq) 0.15
The circadian transcriptional landscape in primary human mammary epithelial cells 0.12
mRNA recovered upon RNF219 IP. [RNA-IP] 0.12
Consequences of Ribosomal Protein Haploinsufficiency in Human Hematopoiesis 0.1
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells (RNA-seq) 0.06
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells 0.06
Identification of a unique gene expression signature in mercury and 2,3,7,8-tetrachlorodibenzo-p-dioxin co-exposed cells 0.06
Co-regulation of transcription by BRG1 and Brm, two mutually exclusive SWI/SNF ATPase subunits 0.05
Cooperative and Antagonistic Transcriptional Regulation by BRG/BRM [RNA-seq] 0.05
Function and hormonal regulation of GATA3 in human first trimester placentation 0.05
Targeting Spt5-Pol II small-molecule inhibitors uncouple distinct activities and reveal additional regulatory roles 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation